keyword
https://read.qxmd.com/read/38657273/tumor-tailored-ionizable-lipid-nanoparticles-facilitate-il-12-circular-rna-delivery-for-enhanced-lung-cancer-immunotherapy
#1
JOURNAL ARTICLE
Shufen Xu, Yue Xu, Nicholas C Solek, Jingan Chen, Fanglin Gong, Andrew James Varley, Alex Golubovic, Anni Pan, Songtao Dong, Gang Zheng, Bowen Li
The advancement of mRNA-based immunotherapies for cancer is highly dependent on the effective delivery of RNA payloads using ionizable lipid nanoparticles (LNPs). However, the clinical application of these therapies is hindered by variable mRNA expression among different cancer types and the risk of systemic toxicity. The transient expression profile of mRNA further complicates this issue, necessitating frequent dosing and thus increasing the potential for adverse effects. Addressing these challenges, we utilized a high-throughput combinatorial method to synthesize and screen LNPs that efficiently deliver circular RNA (circRNA) to lung tumors...
April 24, 2024: Advanced Materials
https://read.qxmd.com/read/38657266/membrane-fusion-liposomes-deliver-antifibrotic-and-chemotherapeutic-drugs-sequentially-to-enhance-tumor-treatment-efficacy-by-reshaping-tumor-microenvironment
#2
JOURNAL ARTICLE
Nan Jia, Qi Wang, Wenpan Li, Dawei Chen, Haiyang Hu
The intricate tumor microenvironment in triple-negative breast cancer (TNBC) hampers chemotherapy and immunotherapy efficacy due to dense extracellular matrix (ECM) by tumor-associated fibroblasts (TAFs). Nanoparticle-based therapies, especially "all in one" nanoparticles, have shown great potential in combined drug delivery strategies to reshape the tumor microenvironment and enhance therapeutic efficiency. However, these "all in one" nanoparticles suffer from limitations in targeting different target cells, uncontrollable dosing ratio, and disregarding the impact of delivery schedules...
April 24, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38657233/first-in-human-stage-iii-iv-melanoma%C3%A2-clinical-trial-of-immune-priming-agent-ifx-hu2-0
#3
JOURNAL ARTICLE
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Delhawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari Pilon-Thomas
IFx-Hu2.0 was designed to encode part of the Emm55 protein contained within a plasmid in a formulation intended for transfection into mammalian cells. IFx-Hu2.0 promotes both adaptive and innate immune responses in animal studies. Furthermore, previous studies have demonstrated safety/efficacy in equine, canine, and murine species. We present the first-in-human study of IFx-Hu2.0, administered by intralesional injection into melanoma tumors of seven patients with stage III/IV unresectable melanoma. No dose-limiting toxicities attributable to IFx-Hu2...
April 24, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38657223/spatial-dissection-of-the-immune-landscape-of-solid-tumors-to-advance-precision-medicine
#4
JOURNAL ARTICLE
Francesco Di Mauro, Giuseppina Arbore
Chemotherapeutics, radiation, targeted therapeutics and immunotherapeutics each demonstrate clinical benefits for a small subset of patients with solid malignancies. Immune cells infiltrating the tumor and the surrounding stroma play a critical role in shaping cancer progression and modulating therapy response. They do this by interacting with the other cellular and molecular components of the tumor microenvironment (TME). Spatial multi-OMICs technologies are rapidly evolving. Currently, such technologies allow high-throughput RNA and protein profiling and retain geographical information about the TME cellular architecture and the functional phenotype of tumor, immune and stromal cells...
April 24, 2024: Cancer Immunology Research
https://read.qxmd.com/read/38657201/correlation-of-immune-fitness-with-response-to-teclistamab-in-relapsed-refractory-multiple-myeloma-in-majestec-1
#5
JOURNAL ARTICLE
Diana Cortes-Selva, Tatiana Perova, Sheri Skerget, Deeksha Vishwamitra, Sarah Stein, Rengasamy Boominathan, On Say Lau, Karl Nielsen, Cuc Davis, Jaymala H Patel, Arnob Banerjee, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Jenna D Goldberg, Lixia Pei, Danielle Trancucci, Suzette Girgis, Shun Xin Wang Lin, Liviawati S Wu, Philippe Moreau, Saad Z Usmani, Nizar J Bahlis, Niels W C J van de Donk, Raluca Verona
Teclistamab, an off-the-shelf B-cell maturation antigen (BCMA) × CD3 bispecific antibody that mediates T-cell activation and subsequent lysis of BCMA-expressing myeloma cells, is approved for the treatment of patients with relapsed/refractory multiple myeloma (RRMM). As a T-cell redirection therapy, clinical outcomes with teclistamab may be influenced by patient immune fitness and tumor antigen expression. We correlated tumor characteristics and baseline immune profiles with clinical response and disease burden in patients with RRMM from the pivotal phase 1/2 MajesTEC-1 study, focusing on patients treated with 1...
April 24, 2024: Blood
https://read.qxmd.com/read/38657195/clinical-presentation-management-and-diagnostic-performance-of-2021-criteria-for-paraneoplastic-neurologic-syndromes-in-childhood
#6
JOURNAL ARTICLE
Ji Zhou, Mei Jin, Yan Su, Xiuwei Zhuo, Libing Fu, Xiaotun Ren, Changhong Ren, Anna Zhou, Jiuwei Li, Weihua Zhang
BACKGROUND AND OBJECTIVES: Paraneoplastic neurologic syndromes (PNSs) are remote neurologic immune-related effects of tumors. The clinical characteristics of pediatric PNSs remain unclear. We retrospectively examined the clinical characteristics of cases of pediatric PNSs and assessed the performance of the 2021 diagnostic criteria in children. METHODS: Patients hospitalized in the Beijing Children's Hospital between June 2015 and June 2023 and fulfilling the description of definite by 2004 diagnostic criteria of PNSs were included...
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38657176/psoriasis-as-a-systemic-disease
#7
REVIEW
Ulrich Mrowietz, Felix Lauffer, Wiebke Sondermann, Sascha Gerdes, Philipp Sewerin
BACKGROUND: Psoriasis was long regarded as an inflammatory disease limited to the skin. Data from dermatologic, rheumatologic and cardiologic research now show it to be a systemic disease, for which the term psoriatic disease is used. METHODS: This paper is based on a selective literature search with special attention to the findings of clinical trials and other current publications, as well as the recommendations of international guidelines. RESULTS: Immunologically mediated inflammation of the skin, arteries, bones, and joints is a central feature of psoriatic disease...
June 28, 2024: Deutsches Ärzteblatt International
https://read.qxmd.com/read/38657120/il1r2-blockade-alleviates-immunosuppression-and-potentiates-anti-pd-1-efficacy-in-triple-negative-breast-cancer
#8
JOURNAL ARTICLE
Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng, Cuicui Liu, Jiahui Xu, Rui Zhang, Quentin Liu, Guohong Hu, Chong Liu, Yi-Zhou Jiang, Zhi-Ming Shao, Ceshi Chen, Suling Liu
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options. Interleukin-1 receptor type 2 (IL1R2) promotes breast tumor-initiating cell (BTIC) self-renewal and tumor growth in TNBC, indicating that targeting it could improve patient treatment. Here, we observed that IL1R2 blockade strongly attenuated macrophage recruitment and the polarization of tumor-associated macrophages (TAMs) to inhibit BTIC self-renewal and CD8+ T cell exhaustion, which resulted in reduced tumor burden and prolonged survival in TNBC mouse models...
April 24, 2024: Cancer Research
https://read.qxmd.com/read/38657065/sphingolipid-biosynthesis-is-essential-for-metabolic-rewiring-during-t-h-17-cell-differentiation
#9
JOURNAL ARTICLE
Thiruvaimozhi Abimannan, Velayoudame Parthibane, Si-Hung Le, Nagampalli Vijaykrishna, Stephen D Fox, Baktiar Karim, Govind Kunduri, Daniel Blankenberg, Thorkell Andresson, Takeshi Bamba, Usha Acharya, Jairaj K Acharya
T helper 17 (TH 17) cells are implicated in autoimmune diseases, and several metabolic processes are shown to be important for their development and function. In this study, we report an essential role for sphingolipids synthesized through the de novo pathway in TH 17 cell development. Deficiency of SPTLC1, a major subunit of serine palmitoyl transferase enzyme complex that catalyzes the first and rate-limiting step of de novo sphingolipid synthesis, impaired glycolysis in differentiating TH 17 cells by increasing intracellular reactive oxygen species (ROS) through enhancement of nicotinamide adenine dinucleotide phosphate oxidase 2 activity...
April 26, 2024: Science Advances
https://read.qxmd.com/read/38657035/century-of-milestones-and-breakthroughs-related-to-the-immune-mechanisms-of-atherosclerosis
#10
REVIEW
Ziad Mallat, Alain Tedgui
No abstract text is available yet for this article.
May 2024: Arteriosclerosis, Thrombosis, and Vascular Biology
https://read.qxmd.com/read/38657027/antigenic-distance-between-primary-and-secondary-dengue-infections-correlates-with-disease-risk
#11
JOURNAL ARTICLE
Lin Wang, Angkana T Huang, Leah C Katzelnick, Noémie Lefrancq, Ana Coello Escoto, Loréna Duret, Nayeem Chowdhury, Richard Jarman, Matthew A Conte, Irina Maljkovic Berry, Stefan Fernandez, Chonticha Klungthong, Butsaya Thaisomboonsuk, Piyarat Suntarattiwong, Warunee Vandepitte, Stephen S Whitehead, Simon Cauchemez, Derek A T Cummings, Henrik Salje
Many pathogens continuously change their protein structure in response to immune-driven selection, resulting in weakened protection even in previously exposed individuals. In addition, for some pathogens, such as dengue virus, poorly targeted immunity is associated with increased risk of severe disease through a mechanism known as antibody-dependent enhancement. However, it remains unclear whether the antigenic distances between an individual's first infection and subsequent exposures dictate disease risk, explaining the observed large-scale differences in dengue hospitalizations across years...
April 24, 2024: Science Translational Medicine
https://read.qxmd.com/read/38657004/n6-methyladenosine-promotes-tnf-mrna-degradation-in-cd4-t-lymphocytes
#12
JOURNAL ARTICLE
Ellen C N van Vroonhoven, Lucas W Picavet, Rianne C Scholman, Lyanne J P M Sijbers, Corlinda R E Kievit, Noortje A M van den Dungen, Michal Mokry, Anouk Evers, Robert J Lebbink, Enric Mocholi, Paul J Coffer, Jorg J A Calis, Sebastiaan J Vastert, Jorg van Loosdregt
N6-methyladenosine (m6A) is a RNA modification that can regulate post-transcriptional processes including RNA stability, translation, splicing and nuclear export. In CD4+ lymphocytes, m6A modifications have been demonstrated to play a role in early differentiation processes. The role of m6A in CD4+ T cell activation and effector function remains incompletely understood. To assess the role of m6A in CD4+ T lymphocyte activation and function, we assessed the transcriptome-wide m6A landscape of human primary CD4+ T cells by methylated RNA immunoprecipitation (meRIP) sequencing...
April 24, 2024: Journal of Leukocyte Biology
https://read.qxmd.com/read/38657003/immunomodulatory-peptides-for-tumor-treatment
#13
REVIEW
Yang Song, Longtianyang Lei, Xingyu Cai, Hua Wei, Cui-Yun Yu
Peptides exhibit various biological activities, including biorecognition, cell targeting, and tumor penetration, and can stimulate immune cells to elicit immune responses for tumor immunotherapy. Peptide self-assemblies and peptide-functionalized nanocarriers can reduce the effect of various biological barriers and the degradation by peptidases, enhancing the efficiency of peptide delivery and improving anti-tumor immune responses. To date, the design and development of peptides with various functionalities have been extensively reviewed for enhanced chemotherapy; however, peptide-mediated tumor immunotherapy using peptides acting on different immune cells, to the knowledge, has not yet been summarized...
April 24, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38656998/antibody-titers-and-the-risk-of-infection-during-the-sars-cov-2-omicron-phase-in-bizen-city-japan
#14
JOURNAL ARTICLE
Tomoka Kadowaki, Ayako Sasaki, Naomi Matsumoto, Toshiharu Mitsuhashi, Hideharu Hagiya, Soshi Takao, Takashi Yorifuji
BACKGROUND: Understanding the association between the immune response and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has implications for forthcoming prevention strategies. We evaluated the association between antibody titers and the risk of infection for the general population during the Omicron-dominant phase. METHODS: This was a prospective cohort study of residents or people affiliated with institutions in Bizen City, which included 1,899 participants...
April 24, 2024: Journal of Infectious Diseases
https://read.qxmd.com/read/38656969/a-fractional-perspective-on-the-transmission-dynamics-of-a-parasitic-infection-considering-the-impact-of-both-strong-and-weak-immunity
#15
JOURNAL ARTICLE
Tao-Qian Tang, Rashid Jan, Zahir Shah, Narcisa Vrinceanu, Ciprian Tanasescu, Asif Jan
Infectious disease cryptosporidiosis is caused by the cryptosporidium parasite, a type of parasitic organism. It is spread through the ingestion of contaminated water, food, or fecal matter from infected animals or humans. The control becomes difficult because the parasite may remain in the environment for a long period. In this work, we constructed an epidemic model for the infection of cryptosporidiosis in a fractional framework with strong and weak immunity concepts. In our analysis, we utilize the well-known next-generation matrix technique to evaluate the reproduction number of the recommended model, indicated by [Formula: see text]...
2024: PloS One
https://read.qxmd.com/read/38656959/long-term-hematopoietic-stem-cells-trigger-quiescence-in-leishmania-parasites
#16
JOURNAL ARTICLE
Laura Dirkx, Sara Van Acker, Yasmine Nicolaes, João Luís Reis Cunha, Rokaya Ahmad, Rik Hendrickx, Ben Caljon, Hideo Imamura, Didier G Ebo, Daniel C Jeffares, Yann G-J Sterckx, Louis Maes, Sarah Hendrickx, Guy Caljon
Addressing the challenges of quiescence and post-treatment relapse is of utmost importance in the microbiology field. This study shows that Leishmania infantum and L. donovani parasites rapidly enter into quiescence after an estimated 2-3 divisions in both human and mouse bone marrow stem cells. Interestingly, this behavior is not observed in macrophages, which are the primary host cells of the Leishmania parasite. Transcriptional comparison of the quiescent and non-quiescent metabolic states confirmed the overall decrease of gene expression as a hallmark of quiescence...
April 24, 2024: PLoS Pathogens
https://read.qxmd.com/read/38656933/impact-of-sars-cov-2-vaccines-on-covid-19-incidence-and-mortality-in-the-united-states
#17
JOURNAL ARTICLE
Fang Fang, John David Clemens, Zuo-Feng Zhang, Timothy F Brewer
BACKGROUND: Given the waning of vaccine effectiveness and the shifting of the most dominant strains in the U.S., it is imperative to understand the association between vaccination coverage and Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) disease and mortality at the community levels and whether that association might vary according to the dominant SARS-CoV-2 strains in the U.S. METHODS: Generalized estimating equations were used to estimate associations between U...
2024: PloS One
https://read.qxmd.com/read/38656918/immunometabolic-signatures-of-circulating-monocytes-in-humans-with-obesity-and-insulin-resistance
#18
JOURNAL ARTICLE
Lisa Smeehuijzen, Anouk Gijbels, Joline P Nugteren-Boogaard, Frank Vrieling, Mehdi Boutagouga Boudjadja, Inez Trouwborst, Kelly M Jardon, Gabby B Hul, Edith J M Feskens, Ellen E Blaak, Gijs H Goossens, Lydia A Afman, Rinke Stienstra
Obesity is associated with chronic inflammation and metabolic complications, including insulin resistance (IR). Immune cells drive inflammation through the rewiring of intracellular metabolism. However, the impact of obesity-related IR on the metabolism and functionality of circulating immune cells, like monocytes, remains poorly understood. To increase insight into the inter-individual variation of immunometabolic signatures among individuals and their role in the development of IR, we assessed systemic and tissue-specific IR and circulating immune markers, and we characterized metabolic signatures and cytokine secretion of circulating monocytes from 194 individuals with a BMI≥25kg/m2...
April 24, 2024: Diabetes
https://read.qxmd.com/read/38656895/reactive-oxygen-species-responsive-dual-anti-inflammatory-and-antioxidative-nanoparticles-for-anterior-uveitis
#19
JOURNAL ARTICLE
Dike Zhang, Jian He, Shi Yuan Hua, Yonghua Li, Min Zhou
Anterior uveitis (AU) is an immune-mediated inflammatory disease that results in iritis, cyclitis, glaucoma, cataracts, and even a loss of vision. The frequent and long-term administration of corticosteroid drugs is limited in the clinic owing to the side effects and patient noncompliance with the drugs. Therefore, specifically delivering drugs to inflammatory anterior segment tissues and reducing the topical application dosage of the drug are still a challenge. Here, we developed dual dexamethasone (Dex) and curcumin (Cur)-loaded reactive oxygen species (ROS)-responsive nanoparticles (CPDC NPs) to treat anterior uveitis...
April 24, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38656888/integrated-multi-omics-analysis-and-machine-learning-identify-hub-genes-and-potential-mechanisms-of-resistance-to-immunotherapy-in-gastric-cancer
#20
JOURNAL ARTICLE
Jinsong Wang, Jia Feng, Xinyi Chen, Yiming Weng, Tong Wang, Jiayan Wei, Yujie Zhan, Min Peng
BACKGROUND: Patients with gastric cancer respond poorly to immunotherapy. There are still unknowns about the biomarkers associated with immunotherapy sensitivity and their underlying molecular mechanisms. METHODS: Gene expression data for gastric cancer were gathered from TCGA and GEO databases. DEGs associated with immunotherapy response came from ICBatlas. KEGG and GO analyses investigated pathways. Hub genes identification employed multiple machine algorithms...
April 22, 2024: Aging
keyword
keyword
15741
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.